Initial research into a potential vaccine being developed at Oxford University have revealed that healthy volunteers, involved in early-stage clinical trials, have experienced a strong immune reaction. The good news doesn’t stop there with similar results being revealed in a Chinese trial in Jiangsu. Paul Moynagh, Professor of Immunology and Director of the Kathleen Lonsdale Institute for Human Health research at NUI Maynooth.
Listen and subscribe to Newstalk Breakfast on Apple Podcasts or Spotify.
Download, listen and subscribe on the Newstalk App.
You can also listen to Newstalk live on newstalk.com or on Alexa, by adding the Newstalk skill and asking: 'Alexa, play Newstalk'.
